SecBot SecBot
SECBOTREPLAY Home › Report › DNTH

DNTH · Three Dianthus Therapeutics insiders (CEO, General Counsel, and a…

Dianthus Therapeutics, Inc. /DE/ · CLUSTER filed Aug 11, 2026 at 17:15 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Aug 11, 2026 at 17:15 ET

Three Dianthus Therapeutics insiders (CEO, General Counsel, and a Director) sold a total of ~$3.2M in open-market shares over a 3-day window, with the CEO alone selling ~$15.6M including option exercises. The sales are large in absolute terms but represent only ~0.05% of the $6.3B market cap, falling below the 0.1% materiality threshold. The CEO's sales coincide with option exercises at $8.44, suggesting tax-planning or diversification rather than a bearish signal, consistent with the weak predictive power of insider sales clusters per academic literature.

  • CEO Marino Garcia sold ~$15.6M in open-market shares (including option exercises at $8.44) on August 7, 2026
  • General Counsel Adam Veness sold ~$1.78M on August 10, 2026
  • Director Anne McGeorge sold ~$845K across multiple trades on August 10, 2026
  • Total open-market sales of ~$3.2M represent ~0.05% of DNTH's $6.3B market cap

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access